Page 22 - Aesthetics&Dermatology_11_2018
P. 22
BIG PHARMA
NOVARTIS RISES TO 2ND
PLACE IN 2018 ACCESS TO
MEDICINE INDEX
Multinational pharmaceutical objectives as part of their individual financial support to patient groups.
company, Novartis has ranked objectives. Novartis also performed strongly
second in the 2018 Access to on product donations, in particular
Medicine Index (ATMi), up from “We are delighted that the Access thanks to the wide geographic
3rdplace in 2016, in recognition to Medicine Index has recognised coverage of its leprosy programme in
of its efforts to improve worldwide our actions to expand access 49 countries.
access to healthcare. to medicines and healthcare to
underserved patients,” said CEO of Among the recognised best
The Index measures the Novartis, Vasant Narasimhan. practices are the dedicated R&D unit
performance of the top-20 “It is a testimony to how our to adapt medicines to the needs of
pharmaceutical companies to approach is evolving, from patients in low- and middle-income
improve access to medicines and philanthropy to scalable and countries; Novartis Access, their
healthcare in developing countries. sustainable approaches, and to our portfolio of medicines against chronic
It covers seven categories: commitment to systematically embed diseases for USD 1 per treatment
access-to-medicine management; access into our business model. We per month, which was expanded to
market influence and compliance; have a long journey ahead of us, new countries in Africa and Asia;
R&D; pricing, manufacturing and and we are committed to doing more SMS for Life, which uses mobile
distribution; patents and licensing; to help get our therapies to more technology to manage medicine
capacity building; and product patients that need them,” continued stocks, train healthcare workers
donations. Narasimhan. and track disease surveillance data;
and ComHIP, supported by the
Novartis remained the industry Novartis rose to 3rd place in the Novartis Foundation and its partners
leader in access-to-medicine R&D category in recognition of its to improve hypertension control
management, and its newly systematic approach to assessing and self-management in Ghana.
launched Access Principles – which its portfolio against the unmet needs Further, the company’s initiatives
aim to systematically integrate of underserved populations through to strengthen care at community
access strategies in how the a dedicated unit. The company rose level and its approach to valuing the
company researches, develops 13 spots to 2nd place in market financial, environmental and social
and delivers medicines globally influence and compliance. impact of its business activities on
– have been highlighted as an society are also highlighted.
innovative practice. The Novartis The ATMi recognised Novartis’
CEO and members of the Executive improved performance in internal
Committee now also have access controls and transparency, including
22
